UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Testicular cancer in 2023: Current status and recent progress

CA: a cancer journal for clinicians, 2024-03, Vol.74 (2), p.167-186

2024

Volltextzugriff (PDF)

Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase-Deficient Renal Cell Carcinoma

Clinical cancer research, 2021-05, Vol.27 (10), p.2910-2919

2021

Volltextzugriff (PDF)

Resistance mechanism to fibroblast growth factor receptor (FGFR) inhibitors in cholangiocarcinoma

Cancer treatment reviews, 2023-12, Vol.121, p.102627-102627, Article 102627

2023

Volltextzugriff (PDF)

PI3K inhibition to overcome endocrine resistance in breast cancer

Expert opinion on investigational drugs, 2018-01, Vol.27 (1), p.1-15

2018

Volltextzugriff (PDF)

Paclitaxel, Ifosfamide, and Cisplatin as Initial Salvage Chemotherapy for Germ Cell Tumors: Long-Term Follow-Up and Outcomes for Favorable- and Unfavorable-Risk Disease

Journal of clinical oncology, 2024-09

2024

Volltextzugriff (PDF)

Supportive care interventions for men with urological cancers: a scoping review

Supportive care in cancer, 2023-09, Vol.31 (9), p.530, Article 530

2023

Volltextzugriff (PDF)

Siliconosis and the long‐term implications of silent breast implant rupture

The breast journal, 2019-09, Vol.25 (5), p.1002-1003

2019

Volltextzugriff (PDF)

The current role for adjuvant and neoadjuvant therapy in renal cell cancer

Current opinion in urology, 2019-11, Vol.29 (6), p.636-642

2019

Volltextzugriff (PDF)

Prognosis Discussion and Referral to Community Palliative Care Services in Patients with Advanced Pancreatic Cancer Treated in a Tertiary Cancer Centre

Healthcare (Basel), 2023-10, Vol.11 (20), p.2802

2023

Volltextzugriff (PDF)

Single institution analysis of glioblastoma multiforme (GBM) outcomes based on year of diagnosis: A 17 year review

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.e14023-e14023

2024

Volltextzugriff (PDF)

Similar overall survival with reduced vs. standard dose bevacizumab monotherapy in progressive glioblastoma

Cancer medicine (Malden, MA), 2020-01, Vol.9 (2), p.469-475

2020

Volltextzugriff (PDF)

Use of Liver Imaging and Biopsy in Clinical Practice

The New England journal of medicine, 2017-12, Vol.377 (23), p.2295

Galán-Puchades, M Teresa

2017

Volltextzugriff (PDF)

Linking in with advice and supports for men impacted by metastatic cancer: The LIAM Mc trial (NCT05946993)

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.TPS1646-TPS1646

2024

Volltextzugriff (PDF)

Impact of next generation sequencing in high grade glioma management

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.e14031-e14031

2024

Volltextzugriff (PDF)

Treatment-induced amenorrhoea for patients with HER2-positive early breast cancer: does it matter?

Translational cancer research, 2018-12, Vol.7 (6), p.1357-1360

2018

Volltextzugriff (PDF)

Defining germline genetics of germ cell tumor: Implications for genetic testing and clinical management

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.5007-5007

2022

Volltextzugriff (PDF)

Adding Pertuzumab to Trastuzumab and Taxanes in HER2 positive breast cancer

Expert opinion on biological therapy, 2018-03, Vol.18 (3), p.251-262

2018

Volltextzugriff (PDF)

Paclitaxel, ifosfamide & cisplatin (TIP) as second-line therapy for germ cell tumors (GCT):Long-term follow-up and expansion cohort

Journal of clinical oncology, 2021-02, Vol.39 (6_suppl), p.386-386

2021

Volltextzugriff (PDF)

Identifying germline genetic alterations or environmental factors associated with bilateral germ cell tumor (GCT)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.5035-5035

2022

Volltextzugriff (PDF)

Response to systemic therapy in patients with metastatic fumarate hydratase (FH) deficient renal cell carcinoma (RCC)

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.686-686

2020

Volltextzugriff (PDF)

Comprehensive Molecular Characterization and Response to Therapy in FH-Deficient Renal Cell Carcinoma

Clinical cancer research, 2021-03, Vol.27 (10), p.2910-2919

2021

Volltextzugriff (PDF)

Real world experience with pembrolizumab and nivolumab for treatment of non-small cell lung cancer (NSCLC) in an Irish Regional Cancer Center

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e21196-e21196

2018

Volltextzugriff (PDF)

Targeting PD-1/PD-L1 in biliary tract cancer: role and available data

Immunotherapy, 2023-05, Vol.15 (7), p.517-530

2023

Volltextzugriff (PDF)

Diagnosing Lynch Syndrome

Irish medical journal, 2016-12, Vol.109 (10), p.487-487

2016

Volltextzugriff (PDF)

Use of Liver Imaging and Biopsy in Clinical Practice

The New England journal of medicine, 2017-12, Vol.377 (23), p.2296

2017

Volltextzugriff (PDF)

1 – 25 von 83

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(64)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Testicular cancer in 2023: Current status and recent progress

Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase-Deficient Renal Cell Carcinoma

Resistance mechanism to fibroblast growth factor receptor (FGFR) inhibitors in cholangiocarcinoma

PI3K inhibition to overcome endocrine resistance in breast cancer

Paclitaxel, Ifosfamide, and Cisplatin as Initial Salvage Chemotherapy for Germ Cell Tumors: Long-Term Follow-Up and Outcomes for Favorable- and Unfavorable-Risk Disease

Supportive care interventions for men with urological cancers: a scoping review

Siliconosis and the long‐term implications of silent breast implant rupture

The current role for adjuvant and neoadjuvant therapy in renal cell cancer

Prognosis Discussion and Referral to Community Palliative Care Services in Patients with Advanced Pancreatic Cancer Treated in a Tertiary Cancer Centre

Single institution analysis of glioblastoma multiforme (GBM) outcomes based on year of diagnosis: A 17 year review

Similar overall survival with reduced vs. standard dose bevacizumab monotherapy in progressive glioblastoma

Use of Liver Imaging and Biopsy in Clinical Practice

Linking in with advice and supports for men impacted by metastatic cancer: The LIAM Mc trial (NCT05946993)

Impact of next generation sequencing in high grade glioma management

Treatment-induced amenorrhoea for patients with HER2-positive early breast cancer: does it matter?

Defining germline genetics of germ cell tumor: Implications for genetic testing and clinical management

Adding Pertuzumab to Trastuzumab and Taxanes in HER2 positive breast cancer

Paclitaxel, ifosfamide & cisplatin (TIP) as second-line therapy for germ cell tumors (GCT):Long-term follow-up and expansion cohort

Identifying germline genetic alterations or environmental factors associated with bilateral germ cell tumor (GCT)

Response to systemic therapy in patients with metastatic fumarate hydratase (FH) deficient renal cell carcinoma (RCC)

Comprehensive Molecular Characterization and Response to Therapy in FH-Deficient Renal Cell Carcinoma

Real world experience with pembrolizumab and nivolumab for treatment of non-small cell lung cancer (NSCLC) in an Irish Regional Cancer Center

Targeting PD-1/PD-L1 in biliary tract cancer: role and available data

Diagnosing Lynch Syndrome

Use of Liver Imaging and Biopsy in Clinical Practice

Suchergebnisse filtern